IL-37b suppresses epithelial mesenchymal transition in hepatocellular carcinoma by inhibiting IL-6/STAT3 signaling
Authors:
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Hepatobiliary & Pancreatic Diseases International
- Vol. 17 (5) , 408-415
Abstract
No abstract availableKeywords
Funding Information
- Chongqing Municipal Education Commission (KJ1400220, cstc2017jcyjAX0224)
This publication has 32 references indexed in Scilit:
- Cancer treatment and survivorship statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- IL-37 inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells of patients with systemic lupus erythematosus: its correlation with disease activityJournal of Translational Medicine, 2014
- Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cellsMolecular Medicine Reports, 2013
- Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinomaHepatology, 2013
- MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expressionHepatology, 2012
- Interleukin‐37 reduces liver inflammatory injury via effects on hepatocytes and non‐parenchymal cellsJournal of Gastroenterology and Hepatology, 2012
- Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cellsHepatology, 2011
- p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathwaysHepatology, 2010
- In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitroNature Protocols, 2007
- The Hallmarks of CancerCell, 2000